Purpose

SIDP is soliciting Infectious Diseases Pharmacotherapy research proposals from SIDP members who qualify as early career investigators (as defined in the Applicant Criteria section below). The primary purpose of this research award is to provide funding for a research project that will further contribute to the development of the principal investigator’s research career and improve their competitiveness for future extramural funding. The research proposal must address a current pharmacotherapy issue(s) surrounding the prevention, diagnosis, and/or treatment of infectious diseases.

Download Request for Proposal

Funding

$20,000 is available to fund a one (1) year, non-renewable grant.

Application Criteria

At the time of application submission, the Principal Investigator (PI) must be a current Full or Associate Member of SIDP and be employed by a non-profit institution. Applications from individuals who are trainees at the time of submission will not be considered. Specifically, applicants enrolled in a PGY1/PGY2/fellowship or graduate degree training program during the award period are ineligible. However, applicants employed in a position eligible to serve as PI at their institution who are enrolled in post-PharmD graduate or non-degree programs are eligible. This award cannot fund work in fulfillment of any graduate degree requirements. Furthermore, the PI must be ≤10 years from completion of their terminal training (e.g., residency, fellowship, graduate degree), not receiving NIH or other peer-reviewed federal funding as PI/site PI at the time of submission, and not received cumulative extramural funding of ≥ $100,000 as PI from any/all funding source(s). Finally, SIDP members who have received an SIDP Research Award as PI in the past two years and members of the SIDP Board of Directors are ineligible to serve as PI for this award. Questions regarding applicant eligibility should be addressed in writing to the Chair of the Research Committee prior to submission.

If a Research Committee member chooses to apply as PI, he/she will be recused from participating in the review or handling of this award. If a Research Committee member chooses to apply as Co-Investigator, mentor, or consultant, he/she will be recused from review of the proposal they are supporting. It is the responsibility of the Committee member to notify the Committee Chair of their intent to participate in an application.

Submission and Review of Proposals

Proposals should follow the guidelines described in the RFPs and be submitted via email to: Chair of the Research Committee, Trang Trinh (trang.trinh@ucsf.edu), Vice Chair of the Research Committee, Greg Tallman (Gregory.Tallman@providence.org), and SIDP’s main email (sidp@affinity-strategies.com). Applications submitted after the application deadline will not be considered.

Proposals must be submitted by email no later than 11:59 PM EST on July 31, 2023.

Anne Gonzales-Luna, PharmD, BCIDP University of Houston College of Pharmacy Project: The Impact of vancomycin resistance in Clostridioides difficile infection

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP Loma Linda University School of Pharmacy Project: Determining the mediators of resistance to SPR206, a novel polymyxin derivative in Acinetobacter baumannii

Katie Olney, PharmD, BCIDP University of Kentucky HealthCare Project: Pharmacokinetic/Pharmacodynamic Evaluation of Fixed-Dose Daptomycin

Julie Ann Justo, PharmD, MS, FIDSA, BCPS-AQ ID University of South Carolina College of Pharmacy Project: Therapeutic Drug Monitoring-Guided Linezolid Dosing for Serious Gram-Positive Bacterial Infections Requiring an Extended Duration of Therapy